Published in Mol Pharmacol on September 01, 1997
Mechanisms of suppression of inducible nitric oxide synthase (iNOS) expression in RAW 264.7 cells by andrographolide. Br J Pharmacol (2000) 1.17
Cortex cinnamomi extract prevents streptozotocin- and cytokine-induced beta-cell damage by inhibiting NF-kappaB. World J Gastroenterol (2006) 0.96
Effects of cyclooxygenase inhibitor pretreatment on nitric oxide production, nNOS and iNOS expression in rat cerebellum. Br J Pharmacol (2003) 0.89
4-trifluoromethyl derivatives of salicylate, triflusal and its main metabolite 2-hydroxy-4-trifluoromethylbenzoic acid, are potent inhibitors of nuclear factor kappaB activation. Br J Pharmacol (1999) 0.86
Aspirin-induced Bcl-2 translocation and its phosphorylation in the nucleus trigger apoptosis in breast cancer cells. Exp Mol Med (2013) 0.84
Alterations in lipid profile, oxidative stress and hepatic function in rat fed with saccharin and methyl-salicylates. Int J Clin Exp Med (2015) 0.78
Preventive effect of zaprinast and 3-isobutyl, 1-methylxanthine (phosphodiesterase inhibitors) on gastric injury induced by nonsteroidal antiinflammatory drugs in rats. Dig Dis Sci (2003) 0.75
Impact of Dendrimers on Solubility of Hydrophobic Drug Molecules. Front Pharmacol (2017) 0.75
Heat balance and the metabolic rate of new-born babies in relation to environmental temperature; and the effect of age and of weight on basal metabolic rate. J Physiol (1965) 3.62
Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol (1993) 3.00
Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes (1992) 2.92
Release of nitric oxide during the T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes. J Immunol (1993) 2.73
Surgical management of multiple polyposis. The problem of cancer in the retained bowel segment. Arch Surg (1970) 2.31
A metabolite-regulated potassium channel in rat pancreatic B cells. Proc Natl Acad Sci U S A (1986) 2.27
Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc Natl Acad Sci U S A (1993) 2.06
Does nitric oxide mediate autoimmune destruction of beta-cells? Possible therapeutic interventions in IDDM. Diabetes (1992) 2.04
Targeted overactivity of beta cell K(ATP) channels induces profound neonatal diabetes. Cell (2000) 1.96
Branched-chain amino acids are essential in the regulation of PHAS-I and p70 S6 kinase by pancreatic beta-cells. A possible role in protein translation and mitogenic signaling. J Biol Chem (1998) 1.85
Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide. J Clin Invest (1992) 1.82
Preliminary characterization of calcium binding in islet-cell plasma membranes. Diabetologia (1980) 1.75
Intracellular Ca2+ mobilization by arachidonic acid. Comparison with myo-inositol 1,4,5-trisphosphate in isolated pancreatic islets. J Biol Chem (1986) 1.70
Oxygen consumption in normally grown, small-for-dates and large-for-dates new-born infants. J Physiol (1968) 1.66
Duplication of the 15q11-13 region in a patient with autism, epilepsy and ataxia. Dev Med Child Neurol (1994) 1.63
Identifying the links between obesity, insulin resistance and beta-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes. Eur J Clin Invest (2002) 1.61
Interleukin-1 beta-induced formation of EPR-detectable iron-nitrosyl complexes in islets of Langerhans. Role of nitric oxide in interleukin-1 beta-induced inhibition of insulin secretion. J Biol Chem (1991) 1.59
Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes (1993) 1.59
Expression of neuregulins and their putative receptors, ErbB2 and ErbB3, is induced during Wallerian degeneration. J Neurosci (1997) 1.57
Permeability of lung capillaries to macromolecules in foetal and new-born lambs and sheep. J Physiol (1969) 1.54
Endotoxin-induced uveitis in the rat is attenuated by inhibition of nitric oxide production. Invest Ophthalmol Vis Sci (1994) 1.53
Effects of sulfonamides on a metabolite-regulated ATPi-sensitive K+ channel in rat pancreatic B-cells. Am J Physiol (1989) 1.51
The routine proctoscopic examination: a second look. Mayo Clin Proc (1966) 1.51
A subcellular fractionation approach for studying insulin release mechanisms and calcium metabolism in islets of Langerhans. Methods Enzymol (1983) 1.48
IL-1 produced and released endogenously within human islets inhibits beta cell function. J Clin Invest (1998) 1.46
Metabolic regulation by leucine of translation initiation through the mTOR-signaling pathway by pancreatic beta-cells. Diabetes (2001) 1.42
Leucine and insulin activate p70 S6 kinase through different pathways in human skeletal muscle. Am J Physiol Endocrinol Metab (2001) 1.40
Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase. J Exp Med (1995) 1.40
IL-1 beta induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: activation of cyclooxygenase by nitric oxide. Biochemistry (1993) 1.36
Rectal prolapse. Causation and surgical treatment. Ann Surg (1970) 1.35
Nitric oxide and cyclic GMP formation induced by interleukin 1 beta in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction. Biochem J (1992) 1.34
Inhibition of nitric oxide formation by guanidines. Eur J Pharmacol (1993) 1.31
Potential role of PKR in double-stranded RNA-induced macrophage activation. EMBO J (2000) 1.29
Cytokines and nitric oxide in islet inflammation and diabetes. Proc Soc Exp Biol Med (1996) 1.29
Biochemical evidence for nitric oxide formation from streptozotocin in isolated pancreatic islets. Biochem Biophys Res Commun (1993) 1.29
Relative hypoglycemia and hyperinsulinemia in mice with heterozygous lipoprotein lipase (LPL) deficiency. Islet LPL regulates insulin secretion. J Biol Chem (1999) 1.28
Interferon-gamma increases the sensitivity of islets of Langerhans for inducible nitric-oxide synthase expression induced by interleukin 1. J Biol Chem (1997) 1.25
Glucose-induced accumulation of inositol trisphosphates in isolated pancreatic islets. Predominance of the 1,3,4-isomer. Biochem J (1986) 1.25
Interleukin 1 is potent modulator of insulin secretion from isolated rat islets of Langerhans. Diabetes (1987) 1.23
Hyperinsulinism in mice with heterozygous loss of K(ATP) channels. Diabetologia (2006) 1.22
Endometrial glands are required for preimplantation conceptus elongation and survival. Biol Reprod (2001) 1.20
Human vascular endothelial cells synthesize and release 24- and 26-carbon polyunsaturated fatty acids. Biochim Biophys Acta (1984) 1.16
Tics and Gilles de la Tourette's syndrome: a follow-up study and critical review. Br J Psychiatry (1969) 1.16
Nitric oxide production in islets from nonobese diabetic mice: aminoguanidine-sensitive and -resistant stages in the immunological diabetic process. Proc Natl Acad Sci U S A (1993) 1.16
Cell-specific translational regulation of S-adenosylmethionine decarboxylase mRNA. Influence of the structure of the 5' transcript leader on regulation by the upstream open reading frame. J Biol Chem (1994) 1.15
Insulin mediates glucose-stimulated phosphorylation of PHAS-I by pancreatic beta cells. An insulin-receptor mechanism for autoregulation of protein synthesis by translation. J Biol Chem (1998) 1.15
Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes. J Immunol (1998) 1.14
Drug treatment of adolescent tiqueurs. A double-blind trial of Diazepam and Haloperidol. Br J Psychiatry (1967) 1.14
The digitonin-permeabilized pancreatic islet model. Effect of myo-inositol 1,4,5-trisphosphate on Ca2+ mobilization. Biochem J (1985) 1.13
Alloxan uptake by isolated rat islets of Langerhans. Endocrinology (1978) 1.13
Double-stranded RNA-induced inducible nitric-oxide synthase expression and interleukin-1 release by murine macrophages requires NF-kappaB activation. J Biol Chem (1998) 1.12
Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium. J Biol Chem (1996) 1.12
Standardization fo a digestion-filtration method for isolation of pancreatic islets. Diabetes (1976) 1.11
The psychologic aspects of proctalgia fugax. Dis Colon Rectum (1965) 1.11
Epithelial autotoxicity of nitric oxide: role in the respiratory cytopathology of pertussis. Proc Natl Acad Sci U S A (1994) 1.09
Mechanisms of beta-cell death in response to double-stranded (ds) RNA and interferon-gamma: dsRNA-dependent protein kinase apoptosis and nitric oxide-dependent necrosis. Am J Pathol (2001) 1.08
Interleukin-1 beta-induced nitric oxide synthase expression by rat pancreatic beta-cells: evidence for the involvement of nuclear factor kappa B in the signaling mechanism. Endocrinology (1995) 1.07
Effect of alloxan on insulin secretion in isolated rat islets perifused in vitro. Diabetes (1974) 1.06
Secretagogue-induced oscillations of cytoplasmic Ca2+ in single beta and alpha-cells obtained from pancreatic islets by fluorescence-activated cell sorting. Biochem Biophys Res Commun (1990) 1.06
Phaeomycotic granuloma in a cat. Vet Pathol (1978) 1.05
Correlation of Ca2+-and calmodulin-dependent protein kinase activity with secretion of insulin from islets of Langerhans. Biochem J (1983) 1.04
Comparison of Streptococcus mutans concentrations in non-banded and banded orthodontic patients. J Dent Res (1981) 1.03
Comparison of the properties of active Ca2+ transport by the islet-cell endoplasmic reticulum and plasma membrane. Biochim Biophys Acta (1983) 1.03
Anal and perianal malignant neoplasms: pathology and treatment. Dis Colon Rectum (1966) 1.03
Selective inhibition of inducible nitric oxide synthase by aminoguanidine. Methods Enzymol (1996) 1.02
Secretagogue-induced diacylglycerol accumulation in isolated pancreatic islets. Mass spectrometric characterization of the fatty acyl content indicates multiple mechanisms of generation. Biochemistry (1989) 1.02
Interleukin 1 inhibits insulin secretion from isolated rat pancreatic islets by a process that requires gene transcription and mRNA translation. J Clin Invest (1990) 1.02
Pancreatic beta-cell damage mediated by beta-cell production of interleukin-1. A novel mechanism for virus-induced diabetes. J Biol Chem (2000) 1.01
Presacral developmental cysts in mother and daughter: report of cases. Dis Colon Rectum (1970) 1.00
Prolonged STAT1 activation is associated with interferon-gamma priming for interleukin-1-induced inducible nitric-oxide synthase expression by islets of Langerhans. J Biol Chem (1999) 1.00
Glucose 6-phosphate regulates Ca2+ steady state in endoplasmic reticulum of islets. A possible link in glucose-induced insulin secretion. J Biol Chem (1986) 1.00
Calmodulin-activated protein kinase activity in rat pancreatic islet cell membranes. Arch Biochem Biophys (1982) 0.99
Protein phosphorylation in permeabilized pancreatic islet cells. Biochem J (1985) 0.98
Interferon-gamma and interleukin-1 beta induce nitric oxide formation from primary mouse astrocytes. Neurosci Lett (1993) 0.98
Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase. J Neuroimmunol (1996) 0.98
Diacylglycerol synthesis de novo from glucose by pancreatic islets isolated from rats and humans. J Clin Invest (1990) 0.97
Fistulas and fistulous abscesses in the anorectal region: personal experience in management. Dis Colon Rectum (1968) 0.97
Irreversible inhibition of metabolic function and islet destruction after a 36-hour exposure to interleukin-1beta. Endocrinology (1997) 0.97
Effect of asphyxia due to umbilical cord occlusion in the foetal lamb on leakage of liquid from the circulation and on permeability of lung capillaries to albumin. J Physiol (1970) 0.97
Evidence that beta cell death in the nonobese diabetic mouse is Fas independent. J Immunol (1999) 0.97
Nitric oxide mediates interleukin-1-induced cellular cytotoxicity in the rat ovary. A potential role for nitric oxide in the ovulatory process. J Clin Invest (1993) 0.97
Nitric oxide mediates IL-1 beta-induced islet dysfunction and destruction: prevention by dexamethasone. Autoimmunity (1993) 0.97
GTP mobilization of Ca2+ from the endoplasmic reticulum of islets. Comparison with myo-inositol 1,4,5-trisphosphate. Biochem J (1987) 0.96
Alloxan inhibition of a Ca2+- and calmodulin-dependent protein kinase activity in pancreatic islets. J Biol Chem (1983) 0.96
Psychotropic drugs and mental retardation: 1. Disabilities and the prescription of drugs for behaviour and for epilepsy in three residential settings. J Ment Defic Res (1990) 0.96
Arachidonic acid metabolism in isolated pancreatic islets. II. The effects of glucose and of inhibitors of arachidonate metabolism on insulin secretion and metabolite synthesis. Biochim Biophys Acta (1984) 0.96
Arachidonic acid metabolism in isolated pancreatic islets. I. Identification and quantitation of lipoxygenase and cyclooxygenase products. Biochim Biophys Acta (1984) 0.96
Tyrosine kinase inhibitors prevent cytokine-induced expression of iNOS and COX-2 by human islets. Am J Physiol (1996) 0.96
Reversibility of interleukin-1 beta-induced islet destruction and dysfunction by the inhibition of nitric oxide synthase. Biochem J (1994) 0.96